Pneumothorax after bevacizumab-containing chemotherapy: a case report.
Yang
Sheng-Hsiang
SH
Division of Hematology-Oncology, Department of Medicine, Taipei Veterans General Hospital, No.201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.
Lin
Jen-Kou
JK
Chen
Wei-Shone
WS
Lin
Tzu-Chen
TC
Yang
Shung-Haur
SH
Jiang
Jeng-Kai
JK
Chang
Shih-Ching
SC
Lan
Yuan-Tzu
YT
Chao
Ta-Chung
TC
Yen
Chueh-Chuan
CC
Tzeng
Cheng-Hwai
CH
Teng
Hao-Wei
HW
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D011030:Pneumothorax / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000628:therapy; D011859:Radiography
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab